Trial intelligence / Profile preview

Phase II study of MenACYW immunogenicity and safety in healthy adolescents

2016-001963-35Phase 2

Sponsor
Sanofi
Start
May 2016
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of Meningococcal ACWY conjugate vaccine in meningococcal disease, sponsored by Sanofi.

02

Drugs

Meningococcal ACWY conjugate vaccine
03

Conditions

meningococcal disease

Beyond the preview

Go deeper on 2016-001963-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-001963-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call